Implementation and verification of PBPK modelling codes of TCDD in rats and humans into Berkeley Madonna
暂无分享,去创建一个
[1] J. Michalek,et al. Comparison of the Use of a Physiologically Based Pharmacokinetic Model and a Classical Pharmacokinetic Model for Dioxin Exposure Assessments , 2005, Environmental health perspectives.
[2] M. DeVito,et al. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[3] Y. Li,et al. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1999, Toxicology and applied pharmacology.
[4] Patricia Ruiz,et al. Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures , 2017, Toxicology and applied pharmacology.
[5] M. DeVito,et al. Use of a Physiologically Based Pharmacokinetic Model for Rats to Study the Influence of Body Fat Mass and Induction of CYP1A2 on the Pharmacokinetics of TCDD , 2006, Environmental health perspectives.